COMP <GO>
ARCC vs CHYM // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Ares Capital Corporation (NASDAQ) VS. Chime Financial Inc. (NASDAQ) • 15-METRIC TALLY: ARCC 8
— CHYM 3
■ METRIC PARITY
LAST: $19.11 (-0.05%) • MKT CAP: $13.81B
options-implied-move
—
LAST: $27.95 (-3.19%) • MKT CAP: $10.93B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARCC VS. CHYM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARCC | CHYM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.00% | -35.00% | +41.00 | ARCC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.69% | -0.42% | -13.27 | CHYM | /fcf-yield <GO> |
| Operating Margin | 41.00% | -47.60% | +88.60 | ARCC | /operating-margins <GO> |
| Net Profit Margin | 33.60% | -46.20% | +79.80 | ARCC | /net-margins <GO> |
| Revenue Growth (YoY) | -2.20% | 30.70% | -32.90 | CHYM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 9.15% | 0.00% | +9.15 | ARCC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | CHYM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.1 | 48.0 | +8.10 | ARCC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.91 | +0.02 | ARCC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.9x | 22.0x | -12.10 | ARCC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.81B | $10.93B | $2.88B | ARCC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARCC REV | CHYM REV | ARCC GROSS % | CHYM GROSS % | ARCC FCF | CHYM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $2.19B | — | 88.0% | -$1.72B | -$45.6M |
| FY 2024 | $0 | $1.67B | — | 87.6% | -$2.13B | -$11.2M |
| FY 2023 | $0 | $1.28B | — | — | $511.0M | -$214.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARCC // BETA 0.93
CHYM // BETA 0.91